Ajanta Pharma Limited
NSE: AJANTPHARM BSE: AJANTPHARM
NSE
2,891.30
29.40 (1.03%)
Prev Close
2861.9
Open Price
2877.7
Volume
123,095
Today Low / High
2845 / 2901.7
52 WK Low / High
2327.3 / 3020.8
Range
2,747 - 3,036
BSE
2,893.20
34.55 (1.21%)
Prev Close
2858.65
Open Price
2858.65
Volume
54,963
Today Low / High
2850 / 2954
52 WK Low / High
2022.05 / 3020.45
Range
2,749 - 3,038
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 2891.3 (target range: 2,747 - 3,036), reflecting a change of 29.4 (1.02729%). On the BSE, it is listed at 2893.2 (target range: 2,749 - 3,038), showing a change of 34.55 (1.20861%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
09 Feb
2,840.00
0.77%
06 Feb
2,828.30
0.86%
05 Feb
2,821.30
-0.14%
04 Feb
2,888.90
-2.34%
03 Feb
2,856.60
0.82%
02 Feb
2,810.00
-0.86%
01 Feb
2,813.00
-0.21%
30 Jan
2,680.00
3.80%
29 Jan
2,704.80
-0.37%
28 Jan
2,711.70
0.24%
27 Jan
2,711.40
-0.48%
23 Jan
2,715.00
-0.57%
22 Jan
2,719.00
-0.05%
21 Jan
2,679.00
1.27%
20 Jan
2,684.00
0.01%
19 Jan
2,680.10
0.21%
16 Jan
2,706.40
-0.94%
14 Jan
2,739.00
-1.19%
Ajanta Pharma Limited Graph
Ajanta Pharma Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Ajanta Pharma Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2,891.30, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 2,893.20 | 2,922.13 | 2,629.92 - 3,214.35 |
| 2,951.06 | 2,360.85 - 3,541.28 | ||
| 2,980.00 | 2,086.00 - 3,873.99 | ||
| Bearish Scenario | 2,893.20 | 2,864.27 | 2,577.84 - 3,150.69 |
| 2,835.34 | 2,268.27 - 3,402.40 | ||
| 2,806.40 | 1,964.48 - 3,648.33 |
Overview of Ajanta Pharma Limited
ISIN
INE031B01049
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
118,000
Market Cap
357,553,262,326
Last Dividend
28
Official Website
IPO Date
2002-07-01
DCF Diff
-5,160.49
DCF
7,856
Financial Ratios Every Investor Needs
Stock Dividend of AJANTPHARM
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-11-10 | November 10, 25 | 28 | 28 | 2025-11-10 | 2025-12-03 | |
| 2024-11-06 | November 06, 24 | 28 | 28 | 2024-11-06 | 2024-11-27 | |
| 2024-02-08 | February 08, 24 | 26 | 26 | 2024-02-08 | 2024-03-01 | |
| 2023-08-04 | August 04, 23 | 10 | 10 | 2023-08-04 | 2023-08-26 | |
| 2022-11-11 | November 11, 22 | 7 | 7 | 2022-11-14 | 2022-12-03 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 4,648.10 Cr | 1,070.76 Cr | 3,577.34 Cr | 0.7696 | 224.00 Cr | 1,099.02 Cr | 2,263.65 Cr | 920.39 Cr | 73.56 | 1,268.32 Cr | 0.1980 |
| 2024-03-31 | 4,208.71 Cr | 1,115.32 Cr | 3,093.39 Cr | 0.7350 | 207.73 Cr | 129.54 Cr | 1,967.73 Cr | 816.17 Cr | 64.82 | 1,256.54 Cr | 0.1939 |
| 2023-03-31 | 3,742.64 Cr | 1,110.20 Cr | 2,632.44 Cr | 0.7034 | 237.01 Cr | 792.73 Cr | 711.07 Cr | 587.98 Cr | 45.89 | 881.40 Cr | 0.1571 |
| 2022-03-31 | 3,284.13 Cr | 886.72 Cr | 2,397.41 Cr | 0.7300 | 204.34 Cr | 652.32 Cr | 781.59 Cr | 712.68 Cr | 54.97 | 1,044.49 Cr | 0.2170 |
| 2021-03-31 | 2,847.02 Cr | 682.39 Cr | 2,164.63 Cr | 0.7603 | 138.91 Cr | 38.40 Cr | 863.72 Cr | 653.87 Cr | 50.06 | 1,024.05 Cr | 0.2297 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 176.24 Cr | 5,014.95 Cr | 1,224.66 Cr | 3,790.2900 Cr | 47.42 Cr | -128.82 Cr | 903.85 Cr | 1,891.77 Cr | 73.76 Cr | 2.00 Cr | 28.95 Cr | 996.1000 Cr |
| 2024-03-31 | 129.49 Cr | 4,638.39 Cr | 1,071.03 Cr | 3,567.3600 Cr | 35.28 Cr | -94.21 Cr | 828.36 Cr | 1,720.98 Cr | 39.32 Cr | 2.34 Cr | 22.74 Cr | 895.7600 Cr |
| 2023-03-31 | 329.83 Cr | 4,679.02 Cr | 1,291.03 Cr | 3,387.9900 Cr | 35.63 Cr | -294.20 Cr | 815.63 Cr | 1,698.16 Cr | 683.93 Cr | 2.67 Cr | 29.00 Cr | 1,139.2800 Cr |
| 2022-03-31 | 206.36 Cr | 4,055.58 Cr | 791.24 Cr | 3,264.3400 Cr | 25.03 Cr | -181.33 Cr | 791.07 Cr | 1,647.42 Cr | 249.35 Cr | 3.00 Cr | 29.42 Cr | 647.3900 Cr |
| 2021-03-31 | 177.51 Cr | 3,778.72 Cr | 783.09 Cr | 2,995.6300 Cr | 31.36 Cr | -146.15 Cr | 766.47 Cr | 1,629.61 Cr | 232.76 Cr | 3.34 Cr | -196.72 Cr | 648.6300 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,157.2300 Cr | -376.5200 Cr | -733.4100 Cr | 839.3100 Cr | 46.0100 Cr | 176.7900 Cr | -317.9200 Cr | 920.3900 Cr | 1.1000 Cr | -349.3700 Cr | -74.5100 Cr |
| 2024-03-31 | 785.0700 Cr | 65.3900 Cr | -1,051.0600 Cr | 632.6600 Cr | -201.4400 Cr | 129.2300 Cr | -152.4100 Cr | 816.1700 Cr | 0.0600 Cr | -642.1700 Cr | -12.3000 Cr |
| 2023-03-31 | 791.7800 Cr | -559.6000 Cr | -107.8700 Cr | 617.2900 Cr | 125.2600 Cr | 330.6700 Cr | -174.4900 Cr | 745.2500 Cr | -0.4900 Cr | -89.6900 Cr | -22.3700 Cr |
| 2022-03-31 | 562.0400 Cr | -74.1000 Cr | -460.0400 Cr | 413.2000 Cr | 28.8800 Cr | 205.4100 Cr | -148.8400 Cr | 909.4800 Cr | 0.2300 Cr | -82.2100 Cr | -25.6600 Cr |
| 2021-03-31 | 576.3100 Cr | -282.3900 Cr | -318.2900 Cr | 404.7000 Cr | -24.7300 Cr | 177.9900 Cr | -171.6100 Cr | 900.1800 Cr | -44.0200 Cr | -82.9000 Cr | -271.4500 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | 1,374.84 Cr | 660.29 Cr | 714.55 Cr | 0.5197 | 338.73 Cr | 273.77 Cr | 21.91 | 407.21 Cr | 0.1991 |
| 2025-09-30 | 1,353.73 Cr | 676.79 Cr | 676.94 Cr | 0.5001 | 325.81 Cr | 260.19 Cr | 20.83 | 387.17 Cr | 0.1922 |
| 2025-06-30 | 1,302.65 Cr | 275.88 Cr | 1,026.77 Cr | 0.7882 | 682.58 Cr | 255.34 Cr | 20.44 | 377.68 Cr | 0.1960 |
| 2025-03-31 | 1,170.41 Cr | 283.42 Cr | 886.99 Cr | 0.7578 | 544.21 Cr | 225.26 Cr | 18.04 | 288.34 Cr | 0.1925 |
| 2024-12-31 | 1,146.13 Cr | 257.81 Cr | 888.32 Cr | 0.7751 | 284.86 Cr | 232.88 Cr | 18.60 | 351.27 Cr | 0.2032 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 91.10 Cr | 848.98 Cr | 940.08 Cr | 1,449.58 Cr | 812.14 Cr | 3,393.64 Cr | 1,977.77 Cr | 5,672.41 Cr | 1,357.40 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 613.85 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -3,790.29 Cr |
| 2025-03-31 | 176.24 Cr | 438.71 Cr | 614.95 Cr | 1,182.74 Cr | 903.85 Cr | 2,843.03 Cr | 1,891.77 Cr | 5,014.95 Cr | 1,224.66 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 741.91 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -3,676.95 Cr |
| 2024-09-30 | 63.89 Cr | 676.98 Cr | 741.91 Cr | 1,036.63 Cr | 845.66 Cr | 2,794.78 Cr | 1,786.78 Cr | 4,790.50 Cr | 1,113.55 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 255.34 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 225.26 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 232.88 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 216.48 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 245.77 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2022-06-22 | June 22, 22 | 3:2 |
| 2015-03-20 | March 20, 15 | 5:2 |
| 2013-09-17 | September 17, 13 | 3:2 |
| 2012-08-09 | August 09, 12 | 2:1 |
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,707.80 | ₹4,097,584,261,766.00 | ₹1,869,940.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,175.50 | ₹1,639,401,215,790.00 | ₹237,885.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹4,079.60 | ₹1,380,722,017,024.00 | ₹192,731.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,256.00 | ₹1,045,705,646,640.00 | ₹1,412,748.00 |
| Lupin Limited | LUPIN | ₹2,204.10 | ₹1,007,203,049,779.00 | ₹692,179.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹887.30 | ₹892,831,419,327.00 | ₹2,272,624.00 |
| Mankind Pharma Limited | MANKIND | ₹2,073.10 | ₹855,786,194,763.00 | ₹260,047.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,811.50 | ₹694,851,997,500.00 | ₹84,504.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,124.10 | ₹652,879,104,414.00 | ₹8,584,281.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,958.00 | ₹552,549,184,022.00 | ₹278,901.00 |
| Laurus Labs Limited | LAURUSLABS | ₹966.35 | ₹521,690,408,016.00 | ₹1,173,246.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,426.20 | ₹361,832,955,712.00 | ₹111,985.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,891.30 | ₹361,226,369,671.00 | ₹123,095.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,923.10 | ₹308,710,523,713.00 | ₹180,306.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,510.30 | ₹286,311,407,162.00 | ₹143,802.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,429.10 | ₹232,217,558,718.00 | ₹2,151,502.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,960.50 | ₹224,012,500,000.00 | ₹10,901.00 |
| Eris Lifesciences Limited | ERIS | ₹1,473.70 | ₹200,742,832,267.00 | ₹52,139.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,502.00 | ₹173,229,161,278.00 | ₹169,474.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹801.90 | ₹157,623,969,136.00 | ₹23,722.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹846.95 | ₹151,697,104,397.00 | ₹446,950.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹936.40 | ₹148,297,432,027.00 | ₹106,196.00 |
| Granules India Limited | GRANULES | ₹581.00 | ₹140,990,523,996.00 | ₹962,030.00 |
| Cohance Lifesciences Limited | COHANCE | ₹353.55 | ₹135,256,612,347.00 | ₹490,988.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,731.70 | ₹131,629,453,963.00 | ₹194,129.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹951.75 | ₹116,813,988,000.00 | ₹55,158.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,498.00 | ₹91,263,402,236.00 | ₹43,098.00 |
| Viyash Scientific Limited | VIYASH | ₹205.01 | ₹89,426,501,651.00 | ₹532,071.00 |
| Strides Pharma Science Limited | STAR | ₹882.50 | ₹81,342,420,105.00 | ₹271,037.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹468.75 | ₹71,766,589,688.00 | ₹129,048.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹764.40 | ₹69,290,791,534.00 | ₹555,300.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹339.70 | ₹66,439,142,895.00 | ₹1,102,745.00 |
| FDC Limited | FDC | ₹397.10 | ₹64,651,884,356.00 | ₹115,013.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹140.55 | ₹45,611,509,193.00 | ₹766,583.00 |
| Innova Captab Limited | INNOVACAP | ₹709.20 | ₹40,583,919,647.00 | ₹15,916.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹338.45 | ₹36,879,293,939.00 | ₹34,394.00 |
| Suven Life Sciences Limited | SUVEN | ₹158.42 | ₹36,036,431,080.00 | ₹148,600.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹688.55 | ₹34,922,639,748.00 | ₹49,277.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹379.50 | ₹34,636,965,000.00 | ₹130,770.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,071.70 | ₹34,263,877,376.00 | ₹15,501.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹317.10 | ₹31,799,582,653.00 | ₹40,449.00 |
Key Executives
Chief Financial Officer
Arvind K. Agrawal
Gender: male
Year Born: 1963
Senior Vice President of Legal, VP of Corporate Affairs, Company Secretary & Compliance Officer
Gaurang C. Shah
Gender: male
Year Born:
President of International Business
H. Nandkishore Agrawal
Gender: male
Year Born: 1960
President of Technical & Operations
H. Satish Agrawal
Gender: male
Year Born: 1963
Executive Vice Chairman of the Board
Madhusudan Bhagwandas Agrawal
Gender: male
Year Born: 1955
Deputy General Manager of Sustainability
Pankaj Barbind
Gender: male
Year Born:
President of Sales & Marketing
Pourus Vakil
Gender: male
Year Born:
Joint MD & Director
Rajesh Mannalal Agrawal
Gender: male
Year Born: 1976
Senior Vice President of HR
Thampy Jacob
Gender: male
Year Born:
MD & Executive Director
Yogesh Mannalal Agrawal
Gender: male
Year Born: 1972
FAQs about Ajanta Pharma Limited
Who is the CEO of the company?
The CEO is Yogesh Mannalal Agrawal.
What is the current market price of the stock?
The current price is ₹2,861.90.
What is the 52-week price range?
The range is ₹2327.3-3020.8.
What is the market capitalization of the company?
The market capitalization is ₹35,755.33 crores.
What is the dividend yield?
The dividend yield is 0.98%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 35.24.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Ajanta Pharma Limited (ISIN: INE031B01049) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹35,755.33 crores and an average daily volume of 118,000 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹28.